BUY Aurobindo Pharma — Nooresh Merani, 12 Aug 2026

byNooresh MeraniHorizon: NA (inferred Swing (≤2wk))12 Aug 2026via CNBC Awaaz.

Entry₹1,662.4Inferred

Target₹1,750

Stop loss₹1,625-2.25% risk

Exit₹1,62514 Aug 2026, 9:50 am

Stop-loss hit-2.25%

Follow Nooresh Merani for new calls(10% target hit, 10 closed calls)Get alerts Watch AUROPHARMA for new buy/sell callsGet alerts See 2 active Swing calls on AUROPHARMA See 263 active Swing picks this week

Not investment advice; past performance doesn't guarantee future results. · Public beta — data is auto-extracted and may contain errors.

AI Assessment

Automated market context for this BUY call — facts from public sources, machine-classified. Not investment advice.

Frozen at close · 14 Aug 2026

12 supporting3 neutral1 opposing

Supports the BUY call (12)

Aurobindo Pharma Ltd has incorporated a new wholly owned subsidiary in India named 'Auropharm Overseas Limited'. The subsidiary will undertake manufacturing and marketing operations.

BSE · Company Update·13 Aug · today

Aurobindo Pharma Expands Margins as Sales Grow

NewsGoogle News·12 Aug · yesterday

Results: Aurobindo Pharma Limited Exceeded Expectations And The Consensus Has Updated Its Estimates

NewsGoogle News·8 Aug · 5d ago

Aurobindo Pharma rises 3% after Q1 beat; HDFC Securities retains 'Add', Axis Securities cuts to 'Hold'

NewsGoogle News·7 Aug · 6d ago

Hold Aurobindo Pharma; target of Rs 1600: Prabhudas Lilladher

NewsGoogle News·7 Aug · 6d ago

Neutral / worth noting (3)

Stock Picks Today: Cummins, Berger Paints, Aurobindo Pharma, Hindalco Novelis, Metropolis, And More On Brokerages' Radar

NewsNdtv-Profit·6 Aug · 1w ago

Aurobindo Pharma has announced its unaudited financial results for the first quarter ended June 30, 2026. The company has provided a press release detailing these results.

NSE · Press Release·5 Aug · 1w ago

Aurobindo Pharma Limited has submitted to the Exchange, the financial results for the period ended Jun 30, 2026.

NSE · Outcome of Board Meeting·5 Aug · 1w ago

Weighs against the BUY call (1)

1 advisor has an active short-term SELL call on this stock, issued in the last 14 days

Advisor consensus · adjacent horizon·6 Aug · 1w ago

Factor classifications are AI-generated from exchange filings, verified news feeds and market data — they can be wrong or incomplete, and are not attributed to the issuing analyst. Verify every factor via its linked original before acting. This is not investment advice.